AP/NTS and LPBN sections were incubated at 4 C for 48 h with rabbit anti-Fos antibody (1:500, Cell signalling technology, Switzerland, Cat# 2250, RRID: AB_2247211), and then after PBS washes, incubated with goat anti-rabbit Alexa Fluor CY3 (1:200, LuBio Science GmbH, Switzerland for Jackson Immunoresearch, Cat# 111-165-144) or alexa fluor 488 for 2 h at room temperature
Oral delivery produces slower absorption with sustained but lower peak plasma concentrations, while subcutaneous injection creates rapid peaks within 15-30 minutes followed by faster clearance
BPC-157 aligns perfectly with this philosophy by addressing the underlying causes of injury and inflammation while supporting the bodys natural healing processes
Interestingly, these effects seem to be independent of age and genetic risk factors (such as APOE4 ), further indicating the possible roles of nootropic diets in mitigating NDD risks [206, 209, 210]